Annual Shareholders Equity:
$732.79M+$301.04M(+69.72%)Summary
- As of today, ACAD annual stockholders equity is $732.79 million, with the most recent change of +$301.04 million (+69.72%) on December 31, 2024.
- During the last 3 years, ACAD annual shareholders equity has risen by +$191.90 million (+35.48%).
- ACAD annual shareholders equity is now at all-time high.
Performance
ACAD Shareholders Equity Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Quarterly Shareholders Equity:
$822.38M+$57.15M(+7.47%)Summary
- As of today, ACAD quarterly stockholders equity is $822.38 million, with the most recent change of +$57.15 million (+7.47%) on June 30, 2025.
- Over the past year, ACAD quarterly shareholders equity has increased by +$305.68 million (+59.16%).
- ACAD quarterly shareholders equity is now at all-time high.
Performance
ACAD Quarterly Shareholders Equity Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Shareholders Equity Formula
Shareholders Equity = Total Assets − Total Liabilities
ACAD Shareholders Equity Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1Y1 Year | +69.7% | +59.2% |
| 3Y3 Years | +35.5% | +89.1% |
| 5Y5 Years | +4.8% | +24.0% |
ACAD Shareholders Equity Highs & Lows
| PeriodPeriod | Annual vs HighAnnual vs High | Annual vs LowAnnual vs Low | Quarter. vs HighQuarter. vs High | Quarter. vs LowQuarter. vs Low | |
|---|---|---|---|---|---|
| 3Y | 3-Year | at high | +83.0% | at high | +127.1% |
| 5Y | 5-Year | at high | +83.0% | at high | +127.1% |
| All-Time | All-Time | at high | +2658.6% | at high | +1661.4% |
ACAD Shareholders Equity History
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2025 | - | $822.38M(+7.5%) |
| Mar 2025 | - | $765.24M(+4.4%) |
| Dec 2024 | $732.79M(+69.7%) | $732.79M(+27.0%) |
| Sep 2024 | - | $577.18M(+11.7%) |
| Jun 2024 | - | $516.70M(+11.3%) |
| Mar 2024 | - | $464.04M(+7.5%) |
| Dec 2023 | $431.75M(+7.8%) | $431.75M(+19.2%) |
| Sep 2023 | - | $362.17M(-8.5%) |
| Jun 2023 | - | $395.79M(+5.8%) |
| Mar 2023 | - | $374.26M(-6.5%) |
| Dec 2022 | $400.41M(-26.0%) | $400.41M(-5.9%) |
| Sep 2022 | - | $425.69M(-2.1%) |
| Jun 2022 | - | $434.85M(-2.2%) |
| Mar 2022 | - | $444.80M(-17.8%) |
| Dec 2021 | $540.89M(-13.7%) | $540.89M(-4.6%) |
| Sep 2021 | - | $566.96M(+0.4%) |
| Jun 2021 | - | $564.84M(-2.9%) |
| Mar 2021 | - | $581.61M(-7.2%) |
| Dec 2020 | $627.01M(-10.3%) | $627.01M(-4.3%) |
| Sep 2020 | - | $654.87M(-1.2%) |
| Jun 2020 | - | $663.01M(+3.9%) |
| Mar 2020 | - | $638.38M(-8.7%) |
| Dec 2019 | $699.13M(+45.9%) | $699.13M(+1.4%) |
| Sep 2019 | - | $689.29M(+77.2%) |
| Jun 2019 | - | $388.91M(-7.0%) |
| Mar 2019 | - | $418.36M(-12.7%) |
| Dec 2018 | $479.08M(+42.9%) | $479.08M(+114.4%) |
| Sep 2018 | - | $223.44M(-15.6%) |
| Jun 2018 | - | $264.72M(-13.0%) |
| Mar 2018 | - | $304.17M(-9.3%) |
| Dec 2017 | $335.29M(-35.3%) | $335.29M(-11.1%) |
| Sep 2017 | - | $377.33M(-9.1%) |
| Jun 2017 | - | $415.14M(-9.3%) |
| Mar 2017 | - | $457.52M(-11.7%) |
| Dec 2016 | $518.41M(+159.5%) | $518.41M(-10.3%) |
| Sep 2016 | - | $578.06M(+41.4%) |
| Jun 2016 | - | $408.81M(-8.2%) |
| Mar 2016 | - | $445.25M(+122.9%) |
| Dec 2015 | $199.76M(-35.5%) | $199.76M(-12.1%) |
| Sep 2015 | - | $227.35M(-11.1%) |
| Jun 2015 | - | $255.82M(-10.3%) |
| Mar 2015 | - | $285.09M(-7.9%) |
| Dec 2014 | $309.49M | $309.49M(-6.4%) |
| Sep 2014 | - | $330.49M(-5.6%) |
| Jun 2014 | - | $350.11M(-4.2%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2014 | - | $365.46M(+100.7%) |
| Dec 2013 | $182.13M(+77.4%) | $182.13M(+0.8%) |
| Sep 2013 | - | $180.75M(-0.4%) |
| Jun 2013 | - | $181.47M(+86.5%) |
| Mar 2013 | - | $97.32M(-5.2%) |
| Dec 2012 | $102.64M(+339.4%) | $102.64M(+481.1%) |
| Sep 2012 | - | $17.66M(+39.0%) |
| Jun 2012 | - | $12.71M(-27.7%) |
| Mar 2012 | - | $17.59M(-24.7%) |
| Dec 2011 | $23.36M(-21.3%) | $23.36M(-17.0%) |
| Sep 2011 | - | $28.14M(-14.3%) |
| Jun 2011 | - | $32.82M(-13.9%) |
| Mar 2011 | - | $38.11M(+28.4%) |
| Dec 2010 | $29.69M(+145.1%) | $29.69M(>+9900.0%) |
| Sep 2010 | - | -$174.00K(-105.5%) |
| Jun 2010 | - | $3.16M(-55.5%) |
| Mar 2010 | - | $7.10M(-41.4%) |
| Dec 2009 | $12.11M(-77.1%) | $12.11M(-36.1%) |
| Sep 2009 | - | $18.97M(-28.2%) |
| Jun 2009 | - | $26.41M(-31.2%) |
| Mar 2009 | - | $38.39M(-27.6%) |
| Dec 2008 | $52.99M(-53.5%) | $52.99M(-20.0%) |
| Sep 2008 | - | $66.24M(-18.4%) |
| Jun 2008 | - | $81.20M(-17.7%) |
| Mar 2008 | - | $98.67M(-13.4%) |
| Dec 2007 | $113.93M(+69.6%) | $113.93M(-12.2%) |
| Sep 2007 | - | $129.73M(-10.1%) |
| Jun 2007 | - | $144.27M(+154.0%) |
| Mar 2007 | - | $56.80M(-15.4%) |
| Dec 2006 | $67.16M(+70.6%) | $67.16M(-14.3%) |
| Sep 2006 | - | $78.40M(-11.5%) |
| Jun 2006 | - | $88.55M(+122.1%) |
| Mar 2006 | - | $39.86M(+1.2%) |
| Dec 2005 | $39.37M(+28.3%) | $39.37M(-20.0%) |
| Sep 2005 | - | $49.20M(-19.5%) |
| Jun 2005 | - | $61.15M(+88.9%) |
| Mar 2005 | - | $32.37M(+5.5%) |
| Dec 2004 | $30.68M(-36.6%) | $30.68M(-17.9%) |
| Sep 2004 | - | $37.36M(-12.7%) |
| Jun 2004 | - | $42.79M(+165.8%) |
| Mar 2004 | - | $16.10M(+130.6%) |
| Dec 2003 | $48.36M(+654.2%) | -$52.67M |
| Dec 2002 | $6.41M(+122.4%) | - |
| Dec 2001 | -$28.64M(-219.4%) | - |
| Dec 2000 | $23.99M | - |
FAQ
- What is ACADIA Pharmaceuticals Inc. annual stockholders equity?
- What is the all-time high annual shareholders equity for ACADIA Pharmaceuticals Inc.?
- What is ACADIA Pharmaceuticals Inc. annual shareholders equity year-on-year change?
- What is ACADIA Pharmaceuticals Inc. quarterly stockholders equity?
- What is the all-time high quarterly shareholders equity for ACADIA Pharmaceuticals Inc.?
- What is ACADIA Pharmaceuticals Inc. quarterly shareholders equity year-on-year change?
What is ACADIA Pharmaceuticals Inc. annual stockholders equity?
The current annual shareholders equity of ACAD is $732.79M
What is the all-time high annual shareholders equity for ACADIA Pharmaceuticals Inc.?
ACADIA Pharmaceuticals Inc. all-time high annual stockholders equity is $732.79M
What is ACADIA Pharmaceuticals Inc. annual shareholders equity year-on-year change?
Over the past year, ACAD annual stockholders equity has changed by +$301.04M (+69.72%)
What is ACADIA Pharmaceuticals Inc. quarterly stockholders equity?
The current quarterly shareholders equity of ACAD is $822.38M
What is the all-time high quarterly shareholders equity for ACADIA Pharmaceuticals Inc.?
ACADIA Pharmaceuticals Inc. all-time high quarterly stockholders equity is $822.38M
What is ACADIA Pharmaceuticals Inc. quarterly shareholders equity year-on-year change?
Over the past year, ACAD quarterly stockholders equity has changed by +$305.68M (+59.16%)